SOC Telemed (TLMD) vs. Its Competitors Head-To-Head Analysis

SOC Telemed (NASDAQ: TLMD) is one of 27 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare SOC Telemed to similar businesses based on the strength of its analyst recommendations, risk, institutional ownership, profitability, valuation, dividends and earnings.

Insider and Institutional Ownership

74.6% of SOC Telemed shares are held by institutional investors. Comparatively, 43.2% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 6.9% of SOC Telemed shares are held by company insiders. Comparatively, 26.4% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares SOC Telemed and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
SOC Telemed $57.99 million -$49.85 million -1.71
SOC Telemed Competitors $1.94 billion $96.17 million 42.17

SOC Telemed’s competitors have higher revenue and earnings than SOC Telemed. SOC Telemed is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares SOC Telemed and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SOC Telemed N/A -96.38% -23.51%
SOC Telemed Competitors -39.15% 16.05% -9.95%

Analyst Recommendations

This is a summary of recent recommendations for SOC Telemed and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SOC Telemed 0 1 5 0 2.83
SOC Telemed Competitors 92 389 536 15 2.46

SOC Telemed currently has a consensus target price of $10.50, suggesting a potential upside of 73.27%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 8.54%. Given SOC Telemed’s stronger consensus rating and higher probable upside, analysts clearly believe SOC Telemed is more favorable than its competitors.

Volatility and Risk

SOC Telemed has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Comparatively, SOC Telemed’s competitors have a beta of 7.07, meaning that their average stock price is 607% more volatile than the S&P 500.

Summary

SOC Telemed competitors beat SOC Telemed on 8 of the 13 factors compared.

SOC Telemed Company Profile

SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.

Receive News & Ratings for SOC Telemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOC Telemed and related companies with MarketBeat.com's FREE daily email newsletter.